Fibrinolysis és érbetegségek.

Translated title of the contribution: Fibrinolysis and vascular diseases

Research output: Contribution to journalReview article

1 Citation (Scopus)


A wide array of in vitro fibrinolysis tests had been performed for a long period, suggesting defective fibrinolysis, mainly impaired tPA response and reserve as major, frequent abnormality, predecessor or causative factor of venous thromboembolism. However, these abnormalities were troublesome to reproduce, and more recently fibrinolytic activators and inhibitors received growing attention as rather atherogenic and less thrombogenic risk factors. Even if it is still not settled, lipoprotein(a) may interfere with fibrinolysis, and seems to carry atherogenic risk, too. The genetic polymorphism of fibrinogen, plasminogen, PAI-1 and some other compounds modifying circulating fibrinogen levels are also discussed in this review.

Translated title of the contributionFibrinolysis and vascular diseases
Original languageHungarian
Pages (from-to)1851-1855
Number of pages5
JournalOrvosi hetilap
Issue number34
Publication statusPublished - Aug 25 1996

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Fibrinolysis and vascular diseases'. Together they form a unique fingerprint.

  • Cite this